Associate Director/Director, Commercial Accounting

Sorry, this job was removed at 04:08 a.m. (CST) on Sunday, Mar 01, 2026
Be an Early Applicant
Bothell, WA, USA
In-Office
181K-242K Annually
Biotech • Pharmaceutical
The Role

Company Overview

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.

Position Overview 

We are seeking an Associate Director/Director, Commercial Accounting to lead the establishment and execution of commercial accounting operations as we prepare to launch our first product. This role will be instrumental in building scalable accounting processes and the internal control framework for revenue recognition, inventory and cost of goods sold, third-party logistics (3PL) accounting, and gross-to-net considerations while partnering closely with Commercial, Supply Chain, and Finance leadership. 

The ideal candidate brings hands-on experience supporting product launches in biotech or life sciences, thrives in a fast-paced, pre-commercial or early-commercial environment, and can balance technical accounting expertise with cross-functional collaboration. 

Responsibilities 

Revenue Recognition & Commercial Accounting 

  • Own and implement ASC 606 revenue recognition policies, procedures, and control activities for product sales. 
  • Manage the development of a model and oversee accounting processes for gross-to-net reserves (e.g., chargebacks, rebates, returns, Medicaid/Medicare, and other government and commercial programs, as applicable). 
  • Oversee accounting for the outsourced order-to-cash process, ensuring accurate billing, revenue cut-off, cash application, and reconciliations. 
  • Prepare and maintain technical accounting memos, internal control narratives, and process documentation to support internal and external audits. 
  • Collaborate with FP&A, Commercial, Market Access, Supply Chain, Legal, and IT teams to align accounting, forecasting, and operational execution. 
  • Provide accounting guidance on new commercial initiatives, pricing strategies, and distribution models in a SOX-controlled environment. 
  • Lead and develop commercial accounting staff and/or external consultants, as appropriate for company size. 
  • Support SEC reporting, audit committee materials, and internal management reporting related to commercial activities. 
  • Serve as a primary point of contact for external auditors for commercial accounting functions, including walkthroughs, control testing, and issue remediation. 

Inventory & COGS 

  • Own accounting for inventory and cost of goods sold (COGS), including costing, overhead rate planning and application, variances, and inventory roll-forwards. 
  • Establish SOX-compliant controls over inventory valuation, reserves, obsolescence, excess inventory, and physical counts. 
  • Ensure reconciliation and completeness controls between operational systems, 3PL reports, and the general ledger. 
  • Provide guidance for ERP and 3PL system implementations, including design, testing, internal controls and audit readiness. 

Requirements 

  • Bachelor’s degree in Accounting or Finance; CPA preferred. 
  • A minimum of 8 years of progressive accounting experience, including experience in a public company subject to SOX 404(b). 
  • Significant experience in biotech, pharmaceutical, or life sciences, with direct exposure to commercial operations. 
  • Demonstrated expertise in ASC 606 revenue recognition, inventory accounting, and cost of goods sold. 

 Knowledge and Skills 

  • Hands-on experience working with 3PLs, CMOs, and distribution partners in a controlled environment. 
  • Strong understanding of SOX internal controls, documentation standards, and audit processes. 
  • Experience building or enhancing accounting processes in a lean, high-growth public company. 
  • Excellent communication and cross-functional collaboration skills. 
  • Ability to operate at both a strategic and detailed execution level. 
  • Experience supporting a first commercial product launch in a public company. 
  • Experience scaling SOX processes post-commercialization. 
Washington State Pay Range
$181,041$242,050 USD

E/E/O

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

E-Verify

Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).

Similar Jobs

CrowdStrike Logo CrowdStrike

Analyst I, Falcon Complete (Hybrid, St Louis)

Cloud • Computer Vision • Information Technology • Sales • Security • Cybersecurity
Remote or Hybrid
USA
10000 Employees
85K-120K Annually

CoreWeave Logo CoreWeave

Recruiter

Cloud • Information Technology • Machine Learning
In-Office
3 Locations
1450 Employees

Opendoor Logo Opendoor

Software Engineer

eCommerce • Fintech • Real Estate • Software • PropTech
Hybrid
Seattle, WA, USA
1600 Employees

CrowdStrike Logo CrowdStrike

Data Engineer

Cloud • Computer Vision • Information Technology • Sales • Security • Cybersecurity
Remote or Hybrid
USA
10000 Employees
195K-290K Annually
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Bothell, Washington
180 Employees

What We Do

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Similar Companies Hiring

SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees
Cencora Thumbnail
Healthtech • Logistics • Pharmaceutical
Conshohocken, PA
51000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account